Significant advances have been made in understanding the molecular and
cellular mechanisms underlying seizure disorders and the actions of a
ntiepileptic drugs. Agents with new mechanisms of action or enhanced a
ctivity via known mechanisms might provide improved seizure control or
more selective therapy for specific epilepsies. Gabapentin is a new a
ntiepileptic drug that is structurally similar to the neurotransmitter
GABA and the endogenous amino acid L-leucine. The mechanism of action
of gabapentin is not fully understood, but its distinct profile of an
ticonvulsant activity in animal seizure models and its lack of activit
y at many drug binding sites associated with other antiepileptic drugs
indicate that its mechanism of action is novel.